FDA Approved: MIFEPRISTONE — Supplemental Application (Corcept Therapeutics Incorporated)

View source ↗

Summary

The FDA approved a supplemental application for mifepristone submitted by Corcept Therapeutics Incorporated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cushing Syndrome

Drugs mentioned

• Mifepristone (mifepristone)

Snippet

SUPPL AP for MIFEPRISTONE (MIFEPRISTONE)